Logo image of NRO.PA

NEURONES (NRO.PA) Stock Fundamental Analysis

Europe - EPA:NRO - FR0004050250 - Common Stock

38.5 EUR
-0.25 (-0.65%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

7

Overall NRO gets a fundamental rating of 7 out of 10. We evaluated NRO against 73 industry peers in the IT Services industry. Both the health and profitability get an excellent rating, making NRO a very profitable company, without any liquidiy or solvency issues. NRO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year NRO was profitable.
NRO had a positive operating cash flow in the past year.
NRO had positive earnings in each of the past 5 years.
In the past 5 years NRO always reported a positive cash flow from operatings.
NRO.PA Yearly Net Income VS EBIT VS OCF VS FCFNRO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

NRO has a Return On Assets of 7.07%. This is in the better half of the industry: NRO outperforms 75.34% of its industry peers.
The Return On Equity of NRO (13.67%) is better than 60.27% of its industry peers.
NRO has a better Return On Invested Capital (11.36%) than 75.34% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NRO is in line with the industry average of 11.06%.
Industry RankSector Rank
ROA 7.07%
ROE 13.67%
ROIC 11.36%
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
NRO.PA Yearly ROA, ROE, ROICNRO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

NRO's Profit Margin of 6.10% is fine compared to the rest of the industry. NRO outperforms 67.12% of its industry peers.
In the last couple of years the Profit Margin of NRO has remained more or less at the same level.
NRO has a Operating Margin of 8.88%. This is in the better half of the industry: NRO outperforms 68.49% of its industry peers.
NRO's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 99.93%, NRO belongs to the best of the industry, outperforming 95.89% of the companies in the same industry.
In the last couple of years the Gross Margin of NRO has remained more or less at the same level.
Industry RankSector Rank
OM 8.88%
PM (TTM) 6.1%
GM 99.93%
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
NRO.PA Yearly Profit, Operating, Gross MarginsNRO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

NRO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
NRO has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NRO has about the same amount of shares outstanding.
The debt/assets ratio for NRO has been reduced compared to a year ago.
NRO.PA Yearly Shares OutstandingNRO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
NRO.PA Yearly Total Debt VS Total AssetsNRO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

NRO has an Altman-Z score of 4.35. This indicates that NRO is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.35, NRO belongs to the best of the industry, outperforming 90.41% of the companies in the same industry.
NRO has a debt to FCF ratio of 0.57. This is a very positive value and a sign of high solvency as it would only need 0.57 years to pay back of all of its debts.
NRO has a Debt to FCF ratio of 0.57. This is amongst the best in the industry. NRO outperforms 89.04% of its industry peers.
NRO has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
NRO has a better Debt to Equity ratio (0.08) than 89.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.57
Altman-Z 4.35
ROIC/WACC1.45
WACC7.86%
NRO.PA Yearly LT Debt VS Equity VS FCFNRO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

NRO has a Current Ratio of 2.31. This indicates that NRO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.31, NRO belongs to the top of the industry, outperforming 94.52% of the companies in the same industry.
NRO has a Quick Ratio of 2.31. This indicates that NRO is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.31, NRO belongs to the best of the industry, outperforming 94.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 2.31
NRO.PA Yearly Current Assets VS Current LiabilitesNRO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

NRO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.56%.
The Earnings Per Share has been growing by 11.23% on average over the past years. This is quite good.
The Revenue has been growing slightly by 7.39% in the past year.
The Revenue has been growing by 9.70% on average over the past years. This is quite good.
EPS 1Y (TTM)4.56%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%

3.2 Future

NRO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.04% yearly.
The Revenue is expected to grow by 5.57% on average over the next years.
EPS Next Y-4.76%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue Next Year6.24%
Revenue Next 2Y5.88%
Revenue Next 3Y5.93%
Revenue Next 5Y5.57%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NRO.PA Yearly Revenue VS EstimatesNRO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
NRO.PA Yearly EPS VS EstimatesNRO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

NRO is valuated rather expensively with a Price/Earnings ratio of 18.51.
Compared to the rest of the industry, the Price/Earnings ratio of NRO indicates a somewhat cheap valuation: NRO is cheaper than 61.64% of the companies listed in the same industry.
NRO is valuated rather cheaply when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
NRO is valuated correctly with a Price/Forward Earnings ratio of 16.57.
NRO's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.57, NRO is valued a bit cheaper.
Industry RankSector Rank
PE 18.51
Fwd PE 16.57
NRO.PA Price Earnings VS Forward Price EarningsNRO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NRO is valued cheaply inside the industry as 83.56% of the companies are valued more expensively.
60.27% of the companies in the same industry are more expensive than NRO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.95
EV/EBITDA 4.97
NRO.PA Per share dataNRO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

NRO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.65
EPS Next 2Y4.65%
EPS Next 3Y8.74%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.35%, NRO has a reasonable but not impressive dividend return.
NRO's Dividend Yield is a higher than the industry average which is at 7.40.
NRO's Dividend Yield is a higher than the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 3.35%

5.2 History

The dividend of NRO is nicely growing with an annual growth rate of 82.05%!
Dividend Growth(5Y)82.05%
Div Incr Years3
Div Non Decr Years3
NRO.PA Yearly Dividends per shareNRO.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

NRO pays out 57.40% of its income as dividend. This is a bit on the high side, but may be sustainable.
NRO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.4%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
NRO.PA Yearly Income VS Free CF VS DividendNRO.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NRO.PA Dividend Payout.NRO.PA Dividend Payout, showing the Payout Ratio.NRO.PA Dividend Payout.PayoutRetained Earnings

NEURONES

EPA:NRO (10/10/2025, 7:00:00 PM)

38.5

-0.25 (-0.65%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)09-10 2025-09-10
Earnings (Next)11-05 2025-11-05
Inst Owners13.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap936.71M
Analysts84
Price Target53.04 (37.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.35%
Yearly Dividend1.2
Dividend Growth(5Y)82.05%
DP57.4%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.19%
Valuation
Industry RankSector Rank
PE 18.51
Fwd PE 16.57
P/S 1.13
P/FCF 12.95
P/OCF 11.1
P/B 2.52
P/tB 3.03
EV/EBITDA 4.97
EPS(TTM)2.08
EY5.4%
EPS(NY)2.32
Fwd EY6.03%
FCF(TTM)2.97
FCFY7.72%
OCF(TTM)3.47
OCFY9.01%
SpS34.2
BVpS15.26
TBVpS12.69
PEG (NY)N/A
PEG (5Y)1.65
Profitability
Industry RankSector Rank
ROA 7.07%
ROE 13.67%
ROCE 15.75%
ROIC 11.36%
ROICexc 28.09%
ROICexgc 41.87%
OM 8.88%
PM (TTM) 6.1%
GM 99.93%
FCFM 8.69%
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.96%
ROCE(5y)16.06%
ROICexcg growth 3YN/A
ROICexcg growth 5Y9.54%
ROICexc growth 3YN/A
ROICexc growth 5Y6.91%
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
F-Score7
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.57
Debt/EBITDA 0.33
Cap/Depr 68.18%
Cap/Sales 1.45%
Interest Coverage 250
Cash Conversion 92.17%
Profit Quality 142.58%
Current Ratio 2.31
Quick Ratio 2.31
Altman-Z 4.35
F-Score7
WACC7.86%
ROIC/WACC1.45
Cap/Depr(3y)79.83%
Cap/Depr(5y)65.86%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.6%
Profit Quality(3y)115.8%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)4.56%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
EPS Next Y-4.76%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%
Revenue Next Year6.24%
Revenue Next 2Y5.88%
Revenue Next 3Y5.93%
Revenue Next 5Y5.57%
EBIT growth 1Y0.45%
EBIT growth 3Y8.08%
EBIT growth 5Y9.67%
EBIT Next Year11.84%
EBIT Next 3Y14.14%
EBIT Next 5Y11.67%
FCF growth 1Y13.09%
FCF growth 3Y7.7%
FCF growth 5Y6.25%
OCF growth 1Y11.34%
OCF growth 3Y9.37%
OCF growth 5Y6.59%